[PDF][PDF] Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors
…, MT Purde, R Niederer, M Porsch, C Lichtensteiger… - Med, 2023 - cell.com
Background Immune checkpoint inhibitors (ICIs) are among the most promising treatment
options for melanoma and non-small cell lung cancer (NSCLC). While ICIs can induce …
options for melanoma and non-small cell lung cancer (NSCLC). While ICIs can induce …
Autoreactive napsin A–specific T cells are enriched in lung tumors and inflammatory lung lesions during immune checkpoint blockade
F Berner, D Bomze, C Lichtensteiger, V Walter… - Science …, 2022 - science.org
Cancer treatment with immune checkpoint blockade (ICB) often induces immune-related
adverse events (irAEs). We hypothesized that proteins coexpressed in tumors and normal cells …
adverse events (irAEs). We hypothesized that proteins coexpressed in tumors and normal cells …
[HTML][HTML] C reactive protein flare predicts response to checkpoint inhibitor treatment in non-small cell lung cancer
…, J Saal, F Berner, C Lichtensteiger… - … for Immunotherapy of …, 2022 - ncbi.nlm.nih.gov
Biomarkers for predicting response to anti-programmed death-1 (PD-1) immune checkpoint
blockade (ICB) in non-small cell lung cancer (NSCLC) remain in demand. Since anti-tumor …
blockade (ICB) in non-small cell lung cancer (NSCLC) remain in demand. Since anti-tumor …
Autoreactive T cells targeting type II pneumocyte antigens in COVID-19 convalescent patients
C Lichtensteiger, M Koblischke, F Berner… - Journal of …, 2023 - Elsevier
Background The role of autoreactive T cells on the course of Coronavirus disease-19 (COVID-19)
remains elusive. Type II pneumocytes represent the main target cells of severe acute …
remains elusive. Type II pneumocytes represent the main target cells of severe acute …
[HTML][HTML] Vitamin C deficiency in blood samples of COVID-19 patients
T Sinnberg, C Lichtensteiger, K Hill-Mündel… - Antioxidants, 2022 - mdpi.com
Coronavirus disease 2019 (COVID-19) is the most notable pandemic of the modern era. A
relationship between ascorbate (vitamin C) and COVID-19 severity is well known, whereas …
relationship between ascorbate (vitamin C) and COVID-19 severity is well known, whereas …
Pulmonary surfactant proteins are inhibited by immunoglobulin A autoantibodies in severe COVID-19
T Sinnberg, C Lichtensteiger, OH Ali… - American journal of …, 2023 - atsjournals.org
Rationale: Coronavirus disease 2019 (COVID-19) can lead to acute respiratory distress
syndrome with fatal outcomes. Evidence suggests that dysregulated immune responses, …
syndrome with fatal outcomes. Evidence suggests that dysregulated immune responses, …
IgA autoantibodies target pulmonary surfactant in patients with severe COVID-19
Complications affecting the lung are hallmarks of severe coronavirus disease 2019 (COVID-19).
While there is evidence for autoimmunity in severe COVID-19, the exact mechanisms …
While there is evidence for autoimmunity in severe COVID-19, the exact mechanisms …
Chest wall abnormalities in Swiss childhood cancer survivors
R Kasteler, C Lichtensteiger, C Schindera, M Ansari… - medRxiv, 2021 - medrxiv.org
Background Chest wall abnormalities are a poorly studied complication after treatment for
childhood cancer. Chest wall abnormalities are not well described in the literature, and little is …
childhood cancer. Chest wall abnormalities are not well described in the literature, and little is …
[HTML][HTML] Validation of questionnaire-reported chest wall abnormalities with a telephone interview in Swiss childhood cancer survivors
Background Chest wall abnormalities are a poorly studied complication after treatment for
childhood cancer. Chest wall abnormalities are not well-described in the literature, and little is …
childhood cancer. Chest wall abnormalities are not well-described in the literature, and little is …
